ARPA-H's SURPASS Aims to Cut Clinical Trials From a Decade to Under 4 Years With AI
BraydonDymm · x · 2026-10-01
ARPA-H launched SURPASS (Simulation-augmented, Real-time Platform Adaptive Seamless Trials) to fix drug development that currently takes 10+ years, costs $1-2 billion, and fails 90% of the time. The program will build perpetual adaptive platform trials combining predictive computational models, shared trial infrastructure, and real-time AI analysis to evaluate drugs faster, cheaper, and with fewer participants — targeting under four years. Funding opportunity is open (ARPA-H-SOL-26-164).
Related event: ARPA-H's SURPASS Aims to Cut Clinical Trials from 10 Years to 4(2 posts)→
More from Apps
- Tip: Connect AI assistant Muse to your school's Canvas to track kids' homework and grades — sytelus · 2026-11-16
- Apple's 4.3 Spam crackdown hits indie devs en masse, even Azam rejected — tinyfool · 2026-11-16
- softFPGA runs Verilog synthesis, P&R and waveform checks in your browser — Obijuan_cube · 2026-11-16
- Open-source TotalSegmentator spots a 42mm dilated aorta on a routine chest CT — MaziyarPanahi · 2026-11-16
- Career prompt of the day: have AI act as your advisor and draft a 90-day action plan — anthara_ai · 2026-11-16
- AI job-search prompt: turn your CV into 10 target roles and LinkedIn keywords — anthara_ai · 2026-11-16